• SCOPE Europe 2024 Best of Show Entries

    Oct 24, 2024, 01:00 by User Not Found
    Clinical Research News | The results are in: there are twelve new product finalists in the 2024 SCOPE Europe Best of Show awards that will be on display next week in Barcelona. Starting at the opening reception, the SCOPE Europe community is invited to identify exceptional innovation in technologies used by life science professionals, voting on the most impactful new products of the year.
    Full story
  • Biopharma PEG Provides Advanced PEG Solutions for Drug Development

    Oct 23, 2024, 08:07 by
    Biopharma PEG has launched a range of polyethylene glycol (PEG) products for PEGylation, improving drug efficacy. With over 40 approved PEGylated drugs, interest in monodispersed PEGs is growing, as seen with Movantik. Biopharma PEG is dedicated to supporting PEGylated drug development.
    Full story
  • Inizio Medical Appoints Patrick Giordani as SVP, AI Solutions Architect, Underpinning Commitment to Expanding AI Capabilities and Accelerating Innovation

    Oct 22, 2024, 08:28 by
    Full story
  • ProPharma Appoints Brian Tuttle as Chief Financial Officer

    Oct 22, 2024, 08:28 by
    Seasoned Life Sciences Executive to Spearhead Financial Strategy and Drive Accelerated Growth
    Full story
  • Drug Developers Eying Rollout of AI Legislation in the EU

    Oct 22, 2024, 01:00 by User Not Found
    Clinical Research News | Eyes around the globe are on the EU Artificial Intelligence (AI) Act—the first comprehensive legal framework on AI anywhere—which will likely influence the direction of regulatory oversight measures adopted elsewhere, include other major markets such as the United States. Differing perspectives on the Act, including if and to what extent it could be a “death knell” for innovation, will be aired during a panel discussion being staged at the upcoming Summit for Clinical Ops Executives (SCOPE) Europe in Barcelona, Spain.
    Full story
  • Estrogen’s Impact on Cancer Reveals New Treatment Options

    Oct 17, 2024, 01:00 by User Not Found
    Clinical Research News | A groundbreaking new approach for treating triple-negative breast cancer is moving forward, thanks to discoveries from Dr. Donald McDonnell’s lab at Duke University. Traditionally, hormone therapies have only been considered effective for estrogen receptor-positive cancers, but McDonnell’s research suggests that estrogen modulation could also impact TNBC.
    Full story
  • CovarsaDx Welcomes Rich Masino as Senior Director of Strategic Partnerships and Business Development

    Oct 16, 2024, 08:28 by
    CovarsaDx, a clinical research organization at the forefront of in vitro diagnostics (IVD) and medical device trials, has appointed Rich Masino as senior director of strategic partnerships and business development. Bringing over 30 years of experience in biotech, pharma, and medical device diagnostics, Masino will focus on driving growth and forging strategic partnerships across CovarsaDx and ZoaDx, while reporting directly to the company’s chief executive officer (CEO).
    Full story
  • Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 - but Uneven Growth for CDMOs

    Oct 16, 2024, 08:28 by
    Full story
  • Psst! Need a Simple and Reliable Eye Tracker for Your Brain Studies?

    Oct 15, 2024, 10:48 by User Not Found
    Clinical Research News | A mechanical engineer at the University of Houston is seeking physician collaborators with a research need for a small but sensitive wearable eye-tracking system to provide continuous data on human brain activity. The need was suggested by a survey of the literature, which found that a shortage of data coming from devices used in supervised clinical settings was resulting in inconclusive correlations study after study.
    Full story
  • PHARMASEAL AND LEDGER RUN FORGE PARTNERSHIP TO ENHANCE CLINICAL BUSINESS OPERATIONS

    Oct 15, 2024, 10:18 by
    PHARMASEAL specializes in state-of-the-art trial management software for life sciences (unified CTMS/eTMF) and LEDGER RUN, INC., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting, contracts and payments, announced their partnership today. Through the partnership, PHARMASEAL’S Engility® Platform software Engility CTMS, Engility eTMF and LEDGER RUN'S unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.
    Full story
  • Inizio Medical Appoints Matt Wadyka as President, US Medical Affairs

    Oct 15, 2024, 09:20 by
    Full story
  • Clario and PathAI Collaborate to Deliver Integrated Solution for GI Clinical Trials

    Oct 11, 2024, 08:20 by
    Partnership combines revolutionary digital pathology and endoscopy solutions, enhancing drug development for IBD and other GI disorders ▪ Strategic Partnership: Streamlined, single-vendor solution, promises to improve diagnostic accuracy, boost efficiency, and enable reliable turnaround times in gastrointestinal (GI) clinical trials. ▪ Advanced GI Solutions: Enhances trial efficiency with AI-powered solutions, including reading for ulcerative colitis (UC) from Clario and histopathology services from PathAI. ▪ Integrated Workflow: Combines endoscopic and histopathology endpoints with simplified processes for CROs, sponsors, and investigational sites.
    Full story
  • Catching Up With Jill Pellegrino, Now Leading AutoCruitment

    Oct 10, 2024, 01:00 by User Not Found
    Clinical Research News | For as long as most people can remember, patient enrollment into clinical trials has been abysmal—so much so that 80% of studies don’t finish on time and 55% end due to low accrual rates. The underlying issue is overreliance on study sites to find participants on their own.
    Full story
  • CluePoints Launches Medical & Safety Review (MSR) Software

    Oct 9, 2024, 01:00 by User Not Found
    Clinical Research News | CluePoints has launched its Medical & Safety Review (MSR) tool that aims to simplify and streamline the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the data history.
    Full story
  • Coronado Research announce engagement of Rob Nichols to support the growth of their Clinical Technology Practice

    Oct 8, 2024, 08:38 by
    Coronado Research announced the engagement of Rob Nichols to support the build-out of its clinical technology practice and advise the executive leadership team as they deliver the broader company vision.
    Full story
  • Curing Data Collection Woes Could Take a Village

    Oct 8, 2024, 01:00 by User Not Found
    Clinical Research News | The average clinical trial generates three times as much data as it did a decade ago, and yet there are no standards in place for how that information should be collected. That’s a big problem for many reasons, not the least of which is that drug developers may be missing key insights about the way interventions are working in individuals and across populations.
    Full story
  • Study Aims to Resolve Variants of Uncertain Significance

    Oct 3, 2024, 01:00 by User Not Found
    Clinical Research News | A pioneering study led by Dr. Lachlan Jolly at the University of Adelaide’s Neurobiology Research Group is transforming genetic diagnostics by resolving variants of uncertain significance (VUS) using skin samples. Many patients with VUS lack a definitive diagnosis because RNA from disease-causing genes often can't be extracted from accessible tissues like blood or skin.
    Full story
  • CovarsaDx Expands Collaborative Efforts Through MDIC Membership and Key Initiatives

    Oct 2, 2024, 06:48 by
    CovarsaDx, a prominent Clinical Research Organization (CRO) renowned for its expertise in vitro diagnostics (IVDs) and medical devices, is proud to announce its membership in the Medical Device Innovation Consortium (MDIC). This partnership marks a significant milestone in CovarsaDx’s ongoing mission to advance innovation in healthcare technology by providing reliable clinical validation results from an elite network of experienced investigators.
    Full story
  • Scope of Things: Trial Planning Skews Conclusions, AI Diversity Help, News of the Month

    Oct 2, 2024, 01:00 by User Not Found
    Clinical Research News | In this month’s episode of the Scope of Things, host Deborah Borfitz covers everything you need to know about a pending launch of a large treatment trial for Graves’ disease, a recruitment campaign for a diagnostic tampon, Walgreens and BARDA’s new partnership, how eligibility criteria has been excluding people of African or Middle Eastern descent from cancer studies, and more.
    Full story
  • ProPharma Names Dawn Sherman Chief Executive Officer

    Oct 1, 2024, 06:59 by
    Full story